Financials

  • Market Capitalization 1.95 B
  • Employee 260
  • Founded 1997
  • CEO N/A
  • Website www.xencor.com
  • Headquarter Delaware, United States
  • FIGI BBG0026ZG4W0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-12.35
Rapporto prezzo/fatturato
9.05

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2006
AGIO
Agios Pharmaceuticals, Inc. - Common Stock
33.58 USD-2.04%+1.63%-6.28%-22.61%2.00 B USD
2017
NBTX
Nanobiotix S.A. - ADSs
41.08 USD-9.03%-5.67%+9.49%+341.72%1.99 B USD
2051
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.78 USD-3.02%-5.09%+6.84%+103.52%1.88 B USD
2052
IMCR
Immunocore Holdings plc - American Depositary Shares
36.38 USD-1.01%-1.14%+8.89%+8.66%1.87 B USD

Notizie